Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: A phase II trial

1. Blanes, M.
2. de la Rubia, J.
3. Lahuerta, J.J.
4. Gonzalez, J.
5. Ribas, P.
6. Solano, C.
7. Alegre, A.
8. Sanz, M.A.